☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
blood-lipid disorders
AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M
December 2, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.